Skip to content

Press Releases

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

Dec 03, 2024

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Nov 07, 2024

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Oct 03, 2024

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Aug 15, 2024

Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Aug 08, 2024

Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire

Jul 30, 2024

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024

Jul 08, 2024

Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device

Jun 18, 2024

Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes

May 23, 2024

Haemonetics Announces Proposed Convertible Senior Notes Offering

May 21, 2024

Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website

May 09, 2024

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024

Apr 10, 2024